Full-Time
Updated on 8/6/2026
Laboratory and pathology testing services
No salary listed
Oxon Hill, MD, USA
In Person
See people who can refer or advise you
Sonic Healthcare USA provides laboratory testing and professional pathology services across the United States as part of Sonic Healthcare Limited, one of the world’s largest medical diagnostics groups. It operates through nine divisions and around eight thousand employees, following a federated model that puts medical leadership at the local level to ensure high-quality, community-based testing for doctors and patients. Its tests cover core diagnostic laboratory services and pathology expertise used by medical practitioners, hospitals, and community health services. The company aims to deliver precise, timely results and strong clinical partnerships to improve patient care by offering comprehensive laboratory testing and pathology support while maintaining close ties to local healthcare providers.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Austin, Texas
Founded
2014
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
Paid Sick Leave
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
BCAL Diagnostics and Sonic Healthcare advance validation of BreastestPlus Version 2 for US market. BCAL Diagnostics (ASX:BDX) has taken a step toward bringing its flagship blood test to the United States by signing a Validation Agreement with Sonic Healthcare USA. The agreement calls for BreastestPlus Version 2 to be transferred to Sonic's CLIA-certified Sonic Reference Laboratory in Austin, Texas, where the assay will be optimised and validated for the US market. The move follows BCAL's aim to establish BreastestPlus Version 2 as a Laboratory Developed Test in the US, a pathway the company describes as the fastest and most efficient route for US market entry. The US breast cancer diagnostics market is large and growing, with more than 40 million mammograms performed annually and roughly 376,000 new breast cancer cases each year. BCAL said successful validation at Sonic's facility would represent a key milestone on that pathway and could lead to commercial licensing discussions between the two organisations. BCAL said it also continues to collect clinical samples from patients across the US in collaboration with leading breast cancer specialists. Those samples will support BCAL's Clinical Outcomes studies, which the company says are necessary for regulatory and reimbursement submissions. Shane Ryan, Chief Executive Officer, BCAL, said, "This Validation Agreement with Sonic Healthcare USA is an important milestone for BCAL Diagnostics and our US commercialisation strategy. Sonic's CLIA-certified laboratory infrastructure and deep expertise in clinical diagnostics provide the right environment to validate BreastestPlus(TM) Version 2. What excites me most is what this brings together - two highly capable teams, united by a shared purpose of delivering better diagnostic solutions for women at scale. We look forward to progressing through the validation process and advancing towards commercial deployment in the world's largest breast cancer diagnostics market." Dr Mohamed Salama, Chief Medical Officer, Sonic Healthcare USA, said, "Sonic Healthcare USA is committed to advancing access to innovative diagnostic solutions that make a real difference to patients. The validation of BreastestPlus(TM) Version 2 at our CLIA-certified Sonic Reference Laboratory in Austin, Texas, reflects that commitment, and we look forward to assessing its performance through a rigorous validation process." The financial terms of the Validation Agreement were not disclosed.
Sonic Healthcare USA, Inc. announces acquisition of Cairo Diagnostics LLC to expand Sonic's national hematology oncology testing capabilities.
Sonic Healthcare USA, Inc. has acquired Cairo Diagnostics LLC to enhance its national hematology oncology testing capabilities. Founded by Dr. Sherif Ibrahim, Cairo is known for its integrated oncology testing approach, combining various diagnostic methods to provide comprehensive reports. This acquisition aims to expand Sonic's reach and improve service to oncologists nationwide, offering faster and more complete diagnostic solutions.
Sonic Healthcare will beef up its presence in Switzerland with the purchase of laboratory group Dr Risch for 117 million Swiss francs ($202m).
Australias largest pathology company has today announced its second German acquisition this month, with binding agreements signed to purchase Medical Laboratori